BKT-P46

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBKT-P46
Drug Alias NameMCP-1/RANTES inhibiting peptide (Biokine)BKT-P46
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionC-C motif chemokine 2 inhibitorsC-C motif chemokine 5 inhibitors
TargetsC-C motif chemokine 2C-C motif chemokine 5
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiokine Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiokine Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A